Le Moigne, R., et. al. EPI-7386, a potent N-terminal domain androgen receptor inhibitor, with a favorable preclinical safety and superior in vitro/in vivo profile, in clinical development for prostate cancer. Prostate Cancer Foundation 27th Annual Scientific Retreat.

Read More > Prostate Cancer Foundation 27th Annual Scientific Retreat Poster